Leishmania donovani targets tumor necrosis factor receptor-associated factor (TRAF) 3 for impairing TLR4-mediated host response
- PMID: 24391131
- DOI: 10.1096/fj.13-238428
Leishmania donovani targets tumor necrosis factor receptor-associated factor (TRAF) 3 for impairing TLR4-mediated host response
Abstract
Intramacrophage pathogen Leishmania donovani escapes host immune response by subverting Toll-like receptor (TLR) signaling, which is critically regulated by protein ubiquitination. In the present study, we identified tumor necrosis factor receptor-associated factor (TRAF) 3, degradative ubiquitination of which is essential for TLR4 activation, as a target for Leishmania to deactivate LPS-mediated TLR4 signaling. We used LPS-treated RAW 264.7 cells and compared the TLR4-mediated immune response in these cells with L. donovani and L. donovani + LPS costimulated macrophages. TRAF3, which was ubiquitinated (2.1-fold over control) at lys 48 position and subsequently degraded following LPS treatment, persisted in L. donovani and L. donovani + LPS costimulated cells due to defective lys 48 ubiquitination. Lys 63-linked ubiquitination of upstream proteins in the cascade (cIAP1/2 and TRAF6), mandatory for TRAF3 degradation, was also reduced postinfection. This may be attributed to reduced association between ubiquitin-conjugating enzyme Ubc13 and TRAF6 during infection. Inhibition of TRAF3 before infection by shRNA in Balb/c mice showed enhanced IL-12 and TNF-α (10.8- and 8.1-fold over infected control) and decreased spleen parasite burden (61.3% suppression, P<0.001), thereby marking reduction in disease progression. Our findings identified TRAF3 as a novel molecular regulator exploited by Leishmania for successful infection.
Keywords: macrophage; signalosome; ubiquitination.
Similar articles
-
IRAK-M regulates the inhibition of TLR-mediated macrophage immune response during late in vitro Leishmania donovani infection.Eur J Immunol. 2015 Oct;45(10):2787-97. doi: 10.1002/eji.201445336. Epub 2015 Jul 21. Eur J Immunol. 2015. PMID: 26140693
-
Leishmania donovani exploits host deubiquitinating enzyme A20, a negative regulator of TLR signaling, to subvert host immune response.J Immunol. 2012 Jul 15;189(2):924-34. doi: 10.4049/jimmunol.1102845. Epub 2012 Jun 8. J Immunol. 2012. PMID: 22685311
-
Leishmania donovani Exploits Tollip, a Multitasking Protein, To Impair TLR/IL-1R Signaling for Its Survival in the Host.J Immunol. 2018 Aug 1;201(3):957-970. doi: 10.4049/jimmunol.1800062. Epub 2018 Jun 15. J Immunol. 2018. PMID: 29907707
-
Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.Immunol Rev. 2011 Nov;244(1):55-74. doi: 10.1111/j.1600-065X.2011.01055.x. Immunol Rev. 2011. PMID: 22017431 Free PMC article. Review.
-
Host resistance to visceral leishmaniasis: prevalence and prevention.Expert Rev Anti Infect Ther. 2016;14(4):435-42. doi: 10.1586/14787210.2016.1160779. Expert Rev Anti Infect Ther. 2016. PMID: 26934623 Review.
Cited by
-
Extracellular fibrinogen-binding protein released by intracellular Staphylococcus aureus suppresses host immunity by targeting TRAF3.Nat Commun. 2022 Sep 19;13(1):5493. doi: 10.1038/s41467-022-33205-z. Nat Commun. 2022. PMID: 36123338 Free PMC article.
-
Interplay Between Sialic Acids, Siglec-E, and Neu1 Regulates MyD88- and TRIF-Dependent Pathways for TLR4-Activation During Leishmania donovani Infection.Front Immunol. 2021 Mar 3;12:626110. doi: 10.3389/fimmu.2021.626110. eCollection 2021. Front Immunol. 2021. PMID: 33763070 Free PMC article.
-
Leishmania donovani inhibits macrophage apoptosis and pro-inflammatory response through AKT-mediated regulation of β-catenin and FOXO-1.Cell Death Differ. 2016 Nov 1;23(11):1815-1826. doi: 10.1038/cdd.2016.101. Epub 2016 Sep 23. Cell Death Differ. 2016. PMID: 27662364 Free PMC article.
-
TRAF3, ubiquitination, and B-lymphocyte regulation.Immunol Rev. 2015 Jul;266(1):46-55. doi: 10.1111/imr.12299. Immunol Rev. 2015. PMID: 26085206 Free PMC article. Review.
-
Deception and manipulation: the arms of leishmania, a successful parasite.Front Immunol. 2014 Oct 20;5:480. doi: 10.3389/fimmu.2014.00480. eCollection 2014. Front Immunol. 2014. PMID: 25368612 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials